Sealy Institute for Drug DiscoveryTargeting Tomorrow​
Precision medicine for the healthier world

The goal of the Sealy Institute for Drug Discovery is to translate cutting-edge scientific discoveries into tangible therapeutic solutions.

By working with a dedicated team of scientists, clinicians, drug developers, and industry partners we strive to develop innovative approaches to diagnosis, treatment, and prevention in the realm of kidney diseases, neurodegeneration, cancer, aging, and infectious diseases. We work across all classes of therapeutics, including small molecule drugs, biologics, and nucleotide-based therapeutics, to address unmet needs for our patients.

The institute has been funded by a generous gift from the Sealy & Smith Foundation, underscoring commitment to advancing the frontiers of biotechnology within an academic setting, with the ultimate goal of improving patient outcomes.

Our Space

The newly renovated Sealy Institute for Drug Discovery contains approximately 14,059 GSF of the recently expanded fifth floor of Building 17 on the UTMB Main Campus. 

SIDD will consist of 9,365 NSF of programmed spaces. It is designed for 24 researchers performing medicinal chemistry synthesis in one large open laboratory - consisting of 24 fume hoods and 24 workstations in the desking area. Adjacent to this are the support labs, consisting of an NMR Suite, LC/MS Suite, Tissue Culture, Protein Production, Assay Development, Microscopy, Chemical Storage, Fridge/Freezer Room, and a Cold Room. There are 8 offices around the exterior of the building, as well as meeting rooms, a computational room and an area for open collaboration.